Member Info for redindi

Buff

I think the clue is in the number of patents, constantly building on previous patents. That is the best way to protect IP, always has been.

WHL

Exactly as I said, they need more data!

WHL

Yes but there is caution and there is caution. The Australian use of the drugs was based on Chinese patients who told the Australians about the drugs.

The point is, it's not all about a vaccine, it never was or is. But, that's the way it's being sold.

And the Donald has said give it to everyone who asks for it... Presidential elections soon.....

Fonzoo

Yes, plenty of positives but not much wide spread media coverage. The only reason I can think for that is it doesn't want to say anything until proven 100%.

If it is, it all changes.

WHL

The one that alleviates is an anti malarial drug. The two that have been named, which I haven't handy, one by Gilead that was developed for Ebola, that has had good results and one that has been used and seen total eradication of the virus is a HIV drug that was used in Australia as was the anti malarial drug.

The others, names not known yet, were used in India.

It seems to me we've been told everything is on hold until there is a vaccine so anything between 9 and 18 months.

Strange really when there's 6/7 drugs mentioned, all that are licensed that have been shown to either cure or alleviate the illness. The only thing they are lacking is data and that is being worked on.

One of the countries that has used the drugs and is about to trial them is Australia with others also in the frame. And the trials and interpretation of the results will not take 9 months or more.

As for the job situation in the US, yes, there are job losses but you can guarantee of any country it will quickly rehire.

Buff

I think you're not the only one who would question the wisdom of announcing deals at this time, if they could be delayed. So why did SEYE announce when as of year end it had 18 months money? Unless, for whatever reason it needed to get the SP up to do a placing.

Phil

Er, not exactly, there are 6/7 drugs that can either alleviate or cure apparently, and they are all approved. I'm with Chris, it's not as bleak as it's made out. Just need time, a lot less than that required for a vaccine, to gather data. In the meantime, take your anti malarial pills!

Chris

Could be the virus doesn't like it hot?

Baxter

As Darren said, at what point do YOU take some personal responsibility for buying, then selling, then buying, then..... You really do need to grow some or go elsewhere

Darren

I'm afraid that's beyond Baxter for a very good reason, he's only 10.

SEYEs previous DW was for
A$8.5 million for I believe one model. Today SEYE announced a A85 million RNS for 24 models which works out at A$3.5 million per model. So, either they've cut their price or something else.

SEYE continuously goes on about how many OEMs it's providing for and yet to date it's only BMWs that are on the road. Just where are the 13 JLRs, a few BMWs and the odd Audi? Just maybe a cash strapped JLR has rebranded the missing 13 so left with 11 models or around A$7.7 million per model. Still less than SEE but about right for SEYE.

Until 2024, maybe it is Volvo although that would be a surprise. Renault is already a customer and look what's happened recently in the US, maybe Tesla who don't really want to do it anyway.

S7

Total bull.

S7

You should be proud, that was a really difficult one, although the odd Black Swan had nothing to do with it. Bravo

S7

I'm sure most on here would agree with the sentiment rather than 1.3p. So, give it a break.

S7

I knew exactly what Sport was talking about, the rest I haven't a clue what you're talking about.

#Team3100

Sport

Again, a very informative and well researched first post on LSE and SEE. Thanks for the input.

Ingold

Just like your previous posts, informative. Thank you for your contribution.

Web

Well spotted, in other words, it will be a going concern as at 30/06 which means it will have 12 months cash.